Alex Keuroghlian, MD MPH: The Push to Get Estrogen FDA-Approved for Gender-Affirming Care (STAT News)

November 27, 2023

Ruta Nonacs, MD PhD

At a time when we are seeing various states limit access to gender-affirming care, FDA approval of estrogen therapy would represent an important step in improving access to gender-affirming care.

Hormone replacement therapy, including estrogen, has been approved by the Food and Drug Administration for the treatment of patients with low estrogen levels, for example women experiencing menopause. A nonprofit group is pursuing research with the goal of gaining FDA approval for the use of estrogen as a gender-affirming treatment for transgender and gender-diverse patients.

In this article published in STAT News, Alex Keuroghlian, MD MPH notes, “It’s critically important to secure FDA approval for gender-affirming hormones and pubertal suppressants.” At a time when we are seeing various states limit access to gender-affirming care, FDA approval would represent an important step in making gender-affirming care accessible to those who need it.